查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941468

益智药市场规模、份额和趋势分析报告：按剂型、分销管道、地区和细分市场预测，2026-2033年

Nootropics Market Size, Share & Trends Analysis Report By Form, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

益智药市场概况

预计到 2025 年，全球益智药市场规模将达到 54.5 亿美元，到 2033 年将达到 114.8 亿美元。

预计从 2026 年到 2033 年，该行业将以 9.1% 的复合年增长率成长。由于该领域的技术进步和现代化，预计该行业在预测期内将经历快速扩张。

预计在预测期内，消费者在各类医疗保健和健康产品上的支出不断增长将推动该行业的成长。此外，这些产品的性价比和易得性预计也将进一步提升消费者对其的需求。

人们对整体健康的日益关注，带动了对天然植物性促智药的需求成长。这些化合物因其植物来源，符合自然、永续和符合伦理的健康理念而备受推崇。秉承整体健康理念，它们被视为提升认知能力、促进身心平衡的有效途径。消费者对健康和保健日益增长的兴趣，推动了这个市场的快速成长。随着越来越多的人进入大学深造，以及低失业率导致劳动市场对高素质人才的需求，求职者们正在寻求自然的方式来提升自身竞争力，并提高工作表现。

未来六年，健康消费者对认知能力提升的需求日益增长，他们希望藉此获得学业和职业上的优势，预计这将推动益智药的需求成长。此外，运动员、运动专业人士和自我提升消费者对这类产品的接受度不断提高，预计也将在预测期内对市场产生正面影响。

由于人口老化以及包括失智症在内的各种脑部疾病和关节炎等问题的发病率不断上升，人们对益智药的需求日益增长。此外，这些产品也用于治疗其他认知障碍和与老龄化相关的疾病，例如过动症和帕金森氏症。忧郁症和其他情绪障碍影响着全球众多消费者。因此，预计未来六年，对情绪增强剂的需求成长也将推动该产业的成长。

为了满足日益增长的益智药需求，製造商们正致力于研发、推出新产品、品管、开发纯素和植物来源产品，以及面向不同细分市场的特色产品。例如，2025年8月，前身为Impact Coffee的Unconform推出了一系列添加了益智成分的冷萃即饮咖啡。这些咖啡旨在改善思维清晰度、延长认知寿命，并促进消化器官系统和免疫健康，且不会产生典型的咖啡因副作用。 250毫升罐装咖啡共有三种口味：馥芮白（睡茄、银杏叶萃取物和维生素B12）、咸焦糖拿铁（添加菊糖和姜黄）以及摩卡（添加烟碱酸和生物素）。每罐售价2.50英镑。此外，Unconform还提供无味的“智能棒”，用于增强免疫力、提升思维清晰度、改善肠道健康和美容功效。一盒10袋售价7.99英镑（约1300日圆）。

目录

第一章调查方法和范围

第二章执行摘要

第三章 益智药市场变数、趋势与范围

  • 市场谱系展望
  • 产业价值链分析
    • 销售/零售通路分析
    • 利润率分析
  • 市场动态
  • 产业分析—波特五力分析
  • 打入市场策略

第四章消费行为分析

  • 人口统计分析
  • 消费者趋势和偏好
  • 影响购买决策的因素
  • 消费品采纳
  • 主要观察结果和发现

第五章 益智药市场：依剂型分類的估算与趋势分析

  • 按类型分類的变化分析和市场份额（2025 年和 2033 年）
  • 胶囊/片剂
  • 粉末
  • 饮料
  • 其他的

第六章 益智药市场：按分销管道分類的估算与趋势分析

  • 2025年及2033年各通路的变化及市占率分析
  • 离线
  • 在线的

第七章 益智药市场：区域估算与趋势分析

  • 区域趋势分析及市场占有率（2025年及2033年）
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲和纽西兰
  • 拉丁美洲
    • 巴西
  • 中东和非洲
    • 阿拉伯聯合大公国

第八章 竞争分析

  • 对主要市场参与企业近期趋势和影响的分析
  • 公司分类
  • 参与企业概况
  • 财务业绩
  • 产品基准测试
  • 企业市场占有率分析（2025 年，%）
  • 公司热力图分析
  • 策略规划
  • 本节分析的主要企业包括：
    • Onnit Labs, Inc.
    • Reckitt Benckiser Group PLC
    • Mental Mojo, LLC
    • NooCube
    • Mind Lab Pro（Performance Lab Group Ltd）
    • TruBrain
    • Neu Mind, LLC
    • Nooflux LLC
    • Zhou Nutrition
    • Kimera Koffee
Product Code: GVR-4-68039-914-3

Nootropics Market Summary

The global nootropics market size was valued at USD 5.45 billion in 2025 and is anticipated to reach USD 11.48 billion by 2033, growing at a CAGR of 9.1% from 2026 to 2033. The industry is expected to expand at a rapid pace over the forecast period on account of technological advancements as well as modernization in the field.

Rising consumer spending on various healthcare as well as wellness products is expected to fuel industry growth over the forecast period. In addition, cost-effectiveness as well as easy accessibility to these products are further expected to boost product needs among consumers.

The demand for natural and plant-based nootropics has increased with growing interest in holistic health. These compounds are recommended because they are sourced from plants and are in line with natural, sustainable, and ethical wellness practices. In keeping with the holistic health concept, they are viewed as a means of improving cognitive performance while encouraging balance between the mind and body. This market surge is a result of the rising consumer focus on health and wellness. With the increasing number of students attending college as well as a workforce that demands better qualifications due to the low unemployment rate, prospective candidates have been seeking natural ways to gain a competitive advantage and improve their performance.

The rising trend of cognitive enhancement among healthy consumers for academic and professional advantage is expected to fuel the need for nootropics over the next six years. In addition, the growing use of the product among athletes and sports professionals, as well as among consumers for personal improvement, will have a positive impact on the market over the forecast period.

The growing geriatric population, coupled with the rising occurrence of various brain-related diseases, including dementia and other issues such as arthritis, has increased the need for nootropics. Moreover, these products are employed for the treatment of other cognitive and age-related disorders, including hyperactivity, as well as Parkinson's disease. Numerous consumers across the globe have been undergoing depression as well as other mood and emotional disorders. Thus, rising demand for mood enhancers is also expected to stimulate industry growth over the next six years.

Manufacturers are responding to the rising demand for nootropics by focusing on research and development, as well as new product launches, quality control, vegan and plant-based options, and specialized products for various niches. For instance, in August 2025, Unconform, formerly Impact Coffee, launched a nootropic-enhanced cold brew RTD coffee line designed to improve mental clarity, cognitive longevity, digestive, and immune health without typical caffeine side effects. The 250ml cans come in three flavors: Flat White (with Ashwagandha, Ginkgo Biloba & Vitamin B12), Salted Caramel Latte (with Inulin and Turmeric), and Mocha (with Niacin & Biotin), priced at £2.50 each. Additionally, Unconform offers Smart Sticks-neutral-flavored sachets that boost immunity, mental clarity, gut health, or beauty, priced at £7.99 for a box of 10 sachets.

Global Nootropics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global nootropics market report on the basis of form, distribution channel, and region:

  • Form Outlook (Revenue, USD Million, 2021 - 2033)
  • Capsules/Tablets
  • Powder
  • Drinks
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Offline
  • Online
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • South Korea
  • Central & South America
    • Brazil
  • Middle East & Africa
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Products & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Product Outlook
  • 2.3. Distribution Channel Outlook
  • 2.4. Regional Outlook

Chapter 3. Nootropics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Sales/Retail Channel Analysis
    • 3.2.2. Profit Margin Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
    • 3.3.3. Market Opportunities
    • 3.3.4. Market Challenges
  • 3.4. Industry Analysis - Porter's Five Forces Analysis
  • 3.5. Market Entry Strategies

Chapter 4. Consumer Behavior Analysis

  • 4.1. Demographics Analysis
  • 4.2. Consumer Trends and Preferences
  • 4.3. Factors Affecting Buying Decision
  • 4.4. Consumer Product Adoption
  • 4.5. Key Observations & Findings

Chapter 5. Nootropics Market: Form Estimates & Trend Analysis

  • 5.1. Form Movement Analysis & Market Share, 2025 & 2033
  • 5.2. Capsules/Tablets
    • 5.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.3. Powder
    • 5.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.4. Drinks
    • 5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.5. Others
    • 5.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. Nootropics Market: Distribution Channel Range Estimates & Trend Analysis

  • 6.1. Distribution Channel Movement Analysis & Market Share, 2025 & 2033
  • 6.2. Offline
    • 6.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.3. Online
    • 6.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. Nootropics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Movement Analysis & Market Share, 2025 & 2033
  • 7.2. North America
    • 7.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.2.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
    • 7.2.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.2.4. U.S.
      • 7.2.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.2.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.2.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.2.5. Canada
      • 7.2.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.2.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.2.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.2.6. Mexico
      • 7.2.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.2.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.2.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
    • 7.3.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.3.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.3.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.3.5. U.K.
      • 7.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.3.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.3.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.3.6. France
      • 7.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.3.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.3.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.3.7. Italy
      • 7.3.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.3.7.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.3.7.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.3.8. Spain
      • 7.3.8.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.3.8.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.3.8.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
    • 7.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.4.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.4.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.4.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.4.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.4.6. Japan
      • 7.4.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.4.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.4.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.4.7.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.4.7.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.4.8. Australia & New Zealand
      • 7.4.8.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.4.8.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.4.8.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
  • 7.5. Central & South America
    • 7.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
    • 7.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.5.4. Brazil
      • 7.5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.5.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.5.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
    • 7.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.6.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.6.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)

Chapter 8. Competitive Analysis

  • 8.1. Recent developments & impact analysis, by key market participants
  • 8.2. Company Categorization
  • 8.3. Participant's Overview
  • 8.4. Financial Performance
  • 8.5. Product Benchmarking
  • 8.6. Company Market Share Analysis, 2025 (%)
  • 8.7. Company Heat Map Analysis
  • 8.8. Strategy Mapping
  • 8.9. List of key companies analyzed in this section include:
    • 8.9.1. Onnit Labs, Inc.
      • 8.9.1.1. Company Overview
      • 8.9.1.2. Financial Performance
      • 8.9.1.3. Product Benchmarking
      • 8.9.1.4. Strategic Initiatives
    • 8.9.2. Reckitt Benckiser Group PLC
      • 8.9.2.1. Company Overview
      • 8.9.2.2. Financial Performance
      • 8.9.2.3. Product Benchmarking
      • 8.9.2.4. Strategic Initiatives
    • 8.9.3. Mental Mojo, LLC
      • 8.9.3.1. Company Overview
      • 8.9.3.2. Financial Performance
      • 8.9.3.3. Product Benchmarking
      • 8.9.3.4. Strategic Initiatives
    • 8.9.4. NooCube
      • 8.9.4.1. Company Overview
      • 8.9.4.2. Financial Performance
      • 8.9.4.3. Product Benchmarking
      • 8.9.4.4. Strategic Initiatives
    • 8.9.5. Mind Lab Pro (Performance Lab Group Ltd)
      • 8.9.5.1. Company Overview
      • 8.9.5.2. Financial Performance
      • 8.9.5.3. Product Benchmarking
      • 8.9.5.4. Strategic Initiatives
    • 8.9.6. TruBrain
      • 8.9.6.1. Company Overview
      • 8.9.6.2. Financial Performance
      • 8.9.6.3. Product Benchmarking
      • 8.9.6.4. Strategic Initiatives
    • 8.9.7. Neu Mind, LLC
      • 8.9.7.1. Company Overview
      • 8.9.7.2. Financial Performance
      • 8.9.7.3. Product Benchmarking
      • 8.9.7.4. Strategic Initiatives
    • 8.9.8. Nooflux LLC
      • 8.9.8.1. Company Overview
      • 8.9.8.2. Financial Performance
      • 8.9.8.3. Product Benchmarking
      • 8.9.8.4. Strategic Initiatives
    • 8.9.9. Zhou Nutrition
      • 8.9.9.1. Company Overview
      • 8.9.9.2. Financial Performance
      • 8.9.9.3. Product Benchmarking
      • 8.9.9.4. Strategic Initiatives
    • 8.9.10. Kimera Koffee
      • 8.9.10.1. Company Overview
      • 8.9.10.2. Financial Performance
      • 8.9.10.3. Product Benchmarking
      • 8.9.10.4. Strategic Initiatives

List of Tables

  • 1. Nootropics Market - Key market driver analysis
  • 2. Nootropics Market - Key market restraint analysis
  • 3. Capsules/tablets nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 4. Nootropics powder market estimates and forecast, 2021 - 2033 (USD Million)
  • 5. Nootropics drinks market estimates and forecast, 2021 - 2033 (USD Million)
  • 6. Other nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 7. Nootropics market estimates and forecast, through online, 2021 - 2033 (USD Million)
  • 8. Nootropics market estimates and forecast, through offline, 2021 - 2033 (USD Million)
  • 9. North America garage organization & storage market estimates and forecast, 2021 - 2033 (USD Million)
  • 10. North America nootropics market, by form, 2021 - 2033 (USD Million)
  • 11. North America nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 12. U.S. nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 13. U.S. nootropics market, by form, 2021 - 2033 (USD Million)
  • 14. U.S. garage organization & storage market, by distribution channel, 2021 - 2033 (USD Million)
  • 15. Canada nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 16. Canada nootropics market, by form, 2021 - 2033 (USD Million)
  • 17. Canada nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 18. Mexico nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 19. Mexico nootropics market, by form, 2021 - 2033 (USD Million)
  • 20. Mexico nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 21. Europe nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 22. Europe nootropics market, by form, 2021 - 2033 (USD Million)
  • 23. Europe nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 24. U.K. nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 25. U.K. nootropics market, by form, 2021 - 2033 (USD Million)
  • 26. U.K. nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 27. Germany nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 28. Germany nootropics market, by form, 2021 - 2033 (USD Million)
  • 29. Germany nootropics market, by application, 2021 - 2033 (USD Million)
  • 30. France nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 31. France nootropics market, by form, 2021 - 2033 (USD Million)
  • 32. France garage organization & storage market, by distribution channel, 2021 - 2033 (USD Million)
  • 33. Italy nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 34. Italy nootropics market, by form, 2021 - 2033 (USD Million)
  • 35. Italy nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 36. Spain nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 37. Spain nootropics market, by form, 2021 - 2033 (USD Million)
  • 38. Spain nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 39. Asia Pacific nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 40. Asia Pacific nootropics market, by form, 2021 - 2033 (USD Million)
  • 41. Asia Pacific nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 42. India nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 43. India nootropics market, by form, 2021 - 2033 (USD Million)
  • 44. India nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 45. China nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 46. China nootropics market, by form, 2021 - 2033 (USD Million)
  • 47. China nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 48. Japan nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 49. Japan nootropics market, by form, 2021 - 2033 (USD Million)
  • 50. Japan nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 51. South Korea nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 52. South Korea nootropics market, by form, 2021 - 2033 (USD Million)
  • 53. South Korea nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 54. Australia & New Zealand nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 55. Australia & New Zealand nootropics market, by form, 2021 - 2033 (USD Million)
  • 56. Australia & New Zealand nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 57. Central & South America nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 58. Central & South America nootropics market, by form, 2021 - 2033 (USD Million)
  • 59. Central & South America nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 60. Brazil nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 61. Brazil nootropics market, by form, 2021 - 2033 (USD Million)
  • 62. Brazil nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 63. Middle East & Africa nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 64. Middle East & Africa nootropics market, by form, 2021 - 2033 (USD Million)
  • 65. Middle East & Africa nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 66. UAE nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 67. UAE nootropics market, by form, 2021 - 2033 (USD Million)
  • 68. UAE nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 69. Vendor Landscape

List of Figures

  • 1. Nootropics Market Snapshot
  • 2. Nootropics Market segmentation & scope
  • 3. Nootropics Market penetration & growth prospect mapping
  • 4. Nootropics Market value chain analysis
  • 5. Nootropics market dynamics
  • 6. Nootropics Market Porter's analysis
  • 7. Nootropics: Form (%) analysis, 2025 & 2033
  • 8. Nootropics: Distribution Channel (%) analysis, 2025 & 2033
  • 9. Nootropics: Regional (%) analysis, 2025 & 2033